HAVEN 2: Emicizumab represents new standard of care for hemophilia A with inhibitorsDecember 9, 2017Hematology
Guidelines cut acute chest syndrome hospital returns in pediatric sickle cellOctober 18, 2017HematologyPulmonology
FDA approves test to screen donated blood for Zika virusOctober 6, 2017ZikaHematologyInfectious Diseases
Solid organ transplantation contributes significantly to incidence of NHL among children and adolescentsAugust 3, 2017HematologySurgery
Vaccination does not eliminate risk for meningococcal disease in eculizumab recipientsJuly 10, 2017VaccinesInfectious DiseasesHematology
Prophylactic emicizumab cut bleeds by 87% in hemophilia A with inhibitorsJuly 10, 2017HematologyAdolescent Medicine
